Honorable Mention The Home Hemodialysis Graft: An access designed to make home cannulation easier and to protect patients from bleeding and other needle related complications

End Stage Renal Disease (ESRD) affects nearly 800,000 people in the US, with the majority relying on hemodialysis (HD) for renal replacement therapy. Hemodialysis access needlerelated injuries (NRI) can result in aneurysms, clotted access, infections, and lethal hemorrhage. Current arteriovenous grafts (AVGs) were not designed specifically for needle puncture and are prone to complications. There is no AVG available that offers immediate cannulation after implantation, facilitates error-proof needle entry, and protects from graft degradation, bleeding, and cannulation injuries. For over 50 years we have been treating our patients with inferior AV access technologies, with no emphasis on protection from injury — InnAVasc Medical has thus specifically developed the InnAVasc Graft (IAVG) with patient safety in mind. The IAVG is designed to provide durable, self-sealing cannulation zones with puncture resistant posterior and sidewall surfaces to 1) protect the patient from painful and dangerous NRIs, 2) allow immediate access, and 3) facilitate the transition to home HD with this easy to use graft. Initial pre-clinical and pilot clinical studies have shown great promise for the IAVG prototypes. Additional funding will enable further development of the IAVG by execution of a US 60-patient clinical study to evaluate safety and effectiveness in subjects with ESRD.

Learn more at innavasc.com